Q-omics provides the consensus-scored CLNS1AP1 profile across patient tissues and cancer cell-line models. CLNS1AP1 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, CLNS1AP1 is differentially expressed in 3, with the highest sampling consensus in HNSC. Additionally, CLNS1AP1 RNA expression shows 6,399 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UVM, HNSC, and STAD as cancer lineages where CLNS1AP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for CLNS1AP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes CLNS1AP1 survival associations across molecular data types. CLNS1AP1 RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible CLNS1AP1 RNA expression–survival associations across cancer types. High CLNS1AP1 expression shows unfavorable associations in UVM, STAD, CESC, KIRC, LUSC and PAAD. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for CLNS1AP1 RNA expression.
This table summarizes CLNS1AP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for CLNS1AP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. CLNS1AP1 shows higher tumor expression in HNSC, COAD and UCEC. The HNSC box plot shows higher CLNS1AP1 RNA expression in tumor versus normal tissue (log2 FC = +0.044, t-test p = .002).
This table shows molecular features associated with CLNS1AP1 in patient tissues and cancer cell lines. In patient samples, CLNS1AP1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
